3. Results
dyspareunia, burning/pain
DYSPAREUNIA
A total of 85 patients were recruited in this study. Five patients did not meet the inclusion criteria. Two participants, one for each group, dropped out at the 8th week for personal reasons unrelated to the study; thus, 78 subjects, 39 in each group, completed the trial (No significant difference in any characteristic was found at baseline between the groups (The between-group difference in VAS scores for burning/pain and dyspareunia was significantly lower after TENS treatment (Comparing data analysis 60- and 120-days post-treatment, the severity score of burning/pain for Group 1 significantly decreased to −17.6% from baseline by day 60, continuing to decrease through treatment before reaching −38.2% at day 120 (